CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.

Plain-language summary

This study examines a multi-level intervention delivered through community opinion leaders to reduce the disproportionate impact of COVID-19 in Latino communities in Philadelphia. It enrolled people who self-identified as Latino or Hispanic and lived in Philadelphia. The study was conducted as a non-phase study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Drexel University

Intervention

Community popular opinion leader (POL) based intervention

Start date

1/15/2021

Estimated completion

3/4/2022

Countries

United States

Related genes

Locations

• Philadelphia, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Self-reported Latino or Hispanic
* Living in Philadelphia

Exclusion Criteria:

\-